Condition
HIV Drug Resistance
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Not Yet Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07146529Not Yet Recruiting
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
NCT03928834Not ApplicableWithdrawn
Sustainable Adherence and Prevention of HIV Drug Resistance in Adolescents
NCT03557021Not ApplicableUnknownPrimary
Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania
NCT02507921UnknownPrimary
Resistance in HIV+ in North and South
Showing all 4 trials